Selective-serotonin reuptake inhibitors for the treatment of hypersensitive esophagus
Authors:
Open Access
- 1 August 2011
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Gastroenterology
- Vol. 4 (5) , 295-300
Abstract
In patients with proton-pump inhibitor (PPI) resistant reflux symptoms, ambulatory 24 h pH impedance monitoring can be used to assess whether a relationship exists between symptoms and reflux episodes. Using this technique it has been suggested that patients with typical reflux symptoms and a normal upper endoscopy should be subclassified as follows: normal endoscopy and abnormal distal acid esophageal exposure (patients with acid reflux); normal endoscopy, with normal distal acid esophageal exposure and a positive symptom association for either acid or nonacid reflux (patients with hypersensitive esophagus); and normal endoscopy, normal distal acid esophageal exposure and a negative symptom association for acid and nonacid reflux (patients with functional heartburn). Although for patients with a normal endoscopy and abnormal distal acid esophageal exposure more aggressive acid suppression can be recommended, managing patients with hypersensitive esophagus and functional heartburn remains a real challenge. Therefore, investigators have evaluated the role of tricyclic antidepressants or selective-serotonin reuptake inhibitors (SSRIs) in influencing esophageal perception. Imipramine has been shown to decrease pain perception in healthy male volunteers and improve symptoms of patients with chest pain and normal coronary angiograms. Trazodone improved symptoms in patients with esophageal contraction abnormalities, while administration of SSRIs lowered chemical and mechanical sensitivity and benefited patients with diffuse esophageal spasm. Furthermore, in a recent study conducted by our group, citalopram administered once daily for 6 months was effective in a select group of patients with hypersensitive esophagus, suggesting that there is a role for SSRIs in the treatment of this disorder.Keywords
This publication has 33 references indexed in Scilit:
- Systematic review: frequency and reasons for consultation for gastro‐oesophageal reflux disease and dyspepsiaAlimentary Pharmacology & Therapeutics, 2009
- Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux diseaseGut, 2009
- The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI DisordersGastroenterology, 2007
- Review article: From gastrin to gastro‐oesophageal reflux disease – a century of acid suppressionAlimentary Pharmacology & Therapeutics, 2006
- Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double‐blind, placebo‐controlled studyAlimentary Pharmacology & Therapeutics, 2006
- Symptom association analysis in ambulatory gastro-oesophageal reflux monitoringGut, 2005
- Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas refluxGut, 2004
- Visceral pain—peripheral sensitisationGut, 2000
- Antidepressant Treatment of Patients with Diffuse Esophageal SpasmJournal of Clinical Gastroenterology, 1999
- Endoscopy‐negative acid reflux diseaseAlimentary Pharmacology & Therapeutics, 1997